Syncom Formulations (India) Ltd's Stock Surges 13%, Outperforms Sector and Sensex

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On August 21, 2024, the company's stock gained 13.01%, closing at Rs 18.65. This positive movement has caught the attention of investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock.

The stock is currently trading close to its 52-week high of Rs 18.65, with a difference of only 1.25%. It has also outperformed the sector by 12.17% today, showcasing its strong performance in the pharmaceutical industry. In fact, the stock has been on a consecutive gain streak for the last 3 days, with a total return of 18.61% in this period.

Today, the stock reached an intraday high of Rs 18.45, showing a high volatility of 8.21% (calculated from weighted average price). This indicates the strong interest and activity surrounding the stock in the market.

Furthermore, Syncom Formulations (India) Ltd is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This is a positive sign for the company's stock and reflects its strong performance in the market.

In comparison to the Sensex, the stock has outperformed with a 1-day performance of 12.09% versus the Sensex's -0.04%. Similarly, in the last month, the stock has shown a 19.49% performance, while the Sensex has only seen a 0.20% increase.

Overall, Syncom Formulations (India) Ltd has been showing strong performance in the stock market, making it an attractive option for investors. With its consistent gains and outperforming the sector and Sensex, the company is definitely one to watch in the pharmaceutical industry.